Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women
- PMID: 18579512
- DOI: 10.1093/humrep/den239
Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women
Abstract
Background: We investigated the differences in anthropometrical, hormonal and insulin resistance parameters according to the subtype of polycystic ovary syndrome (PCOS) in Korean women.
Methods: We recruited 166 women with PCOS and retrospectively recruited 277 controls. PCOS was diagnosed by irregular menstruation (IM), polycystic ovary (PCO) and hyperandrogenism (HA). Subjects were divided into four subgroups: the IM/HA/PCO group (n = 87, 52.4%), the IM/PCO group (n = 52, 31.3%), the IM/HA group (n = 23, 13.9%) and the HA/PCO group (n = 4, 2.4%). Clinical and biochemical variables were compared among the PCOS subgroups.
Results: The IM/HA/PCO and IM/HA groups showed higher body mass index (P < 0.001) and waist-to-hip ratio (P < 0.001) than the IM/PCO group. The IM/HA group had higher triglyceride levels than the other groups (P < 0.001). Higher fasting insulin (P < 0.001) and postprandial 2 h insulin (P < 0.01) were noted in the IM/HA/PCO group and the IM/HA group, compared with the IM/PCO group. Women with PCOS showed lower sex hormone-binding globulin (P < 0.001) and higher systolic blood pressure (BP) (P = 0.004), diastolic BP (P = 0.001), fasting insulin (P < 0.001), postprandial 2 h insulin (P < 0.001), homeostatic model for insulin resistance (P < 0.001) and clinical and biochemical parameters of metabolic syndrome (P < 0.05) compared with subjects without PCOS.
Conclusions: Women with PCOS without HA are common in Korea and are less likely to have metabolic dysfunction, insulin resistance and elevated BP. PCOS without HA may be a mild phenotype of PCOS. Therefore, women with PCOS in Korea could have a reduced likelihood of having metabolic syndrome compared with women of other ethnicities.
Similar articles
-
Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.Clin Endocrinol (Oxf). 2007 Apr;66(4):513-7. doi: 10.1111/j.1365-2265.2007.02764.x. Clin Endocrinol (Oxf). 2007. PMID: 17371468
-
Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.J Obstet Gynaecol Res. 2011 Aug;37(8):1020-6. doi: 10.1111/j.1447-0756.2010.01478.x. Epub 2011 Apr 12. J Obstet Gynaecol Res. 2011. PMID: 21481088
-
[Exploration of the classification of polycystic ovarian syndrome].Zhonghua Fu Chan Ke Za Zhi. 2006 Oct;41(10):684-8. Zhonghua Fu Chan Ke Za Zhi. 2006. PMID: 17199924 Chinese.
-
The impact of obesity on reproduction in women with polycystic ovary syndrome.BJOG. 2006 Oct;113(10):1148-59. doi: 10.1111/j.1471-0528.2006.00990.x. Epub 2006 Jul 7. BJOG. 2006. PMID: 16827825 Review.
-
Polycystic ovary syndrome and type 2 diabetes mellitus.Minerva Ginecol. 2004 Feb;56(1):53-62. Minerva Ginecol. 2004. PMID: 14973410 Review.
Cited by
-
Serum visfatin levels in non-obese women with polycystic ovary syndrome and matched controls.Obstet Gynecol Sci. 2018 Mar;61(2):253-260. doi: 10.5468/ogs.2018.61.2.253. Epub 2018 Feb 5. Obstet Gynecol Sci. 2018. PMID: 29564317 Free PMC article.
-
Tumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical, biochemical, and molecular genetic study.Genet Test Mol Biomarkers. 2014 Sep;18(9):605-9. doi: 10.1089/gtmb.2014.0151. Epub 2014 Aug 1. Genet Test Mol Biomarkers. 2014. PMID: 25083576 Free PMC article. Clinical Trial.
-
Gestational Diabetes Mellitus and Metabolic Disorder Among the Different Phenotypes of Polycystic Ovary Syndrome.Oman Med J. 2017 May;32(3):214-220. doi: 10.5001/omj.2017.40. Oman Med J. 2017. PMID: 28584602 Free PMC article.
-
Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome.Clin Exp Reprod Med. 2013 Jun;40(2):100-5. doi: 10.5653/cerm.2013.40.2.100. Epub 2013 Jun 30. Clin Exp Reprod Med. 2013. PMID: 23875167 Free PMC article.
-
Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine.Ann Saudi Med. 2010 Jul-Aug;30(4):278-83. doi: 10.4103/0256-4947.65255. Ann Saudi Med. 2010. PMID: 20622344 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical